Ono and Galapagos Sign an Additional Target Discovery Agreement

News   May 30, 2012

 
Ono and Galapagos Sign an Additional Target Discovery Agreement
 
 
 

RELATED ARTICLES

Finding Drug Targets for Obesity, Diabetes

News

Technological breakthrough will likely be of great interest to biotechnology companies aspiring to build their drug pipeline in the metabolic disease area.

READ MORE

Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF Diagnostics

News

EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body now available on Ortho’s VITROS® 4600 Chemistry System and VITROS® 5600 Integrated System.

READ MORE

Fabric Genomics Partners to Improve Pediatric Care

News

Partnerships with Genomics England, Rady Children's Institute for Genomic Medicine, and The Utah Genome Project demonstrate diagnostic utility of Fabric Genomics' algorithm-based genome analysis.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE